Products

StrateQueue

The fastest way from backtest to live trading

stratequeue.com Source★ 84AGPL-3.0Finance / Investing & Trading

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
Samuel Tinnerholm
@samtinnerholm· 815 followers
Launched
17mo ago
2025-07-08 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    The fastest way from backtest to live trading

    Jul 8, 2025 · 17mo agoLaunch page

Open Source & Agent Ecosystem

GitHub · MCP / Skill
Last commit 2026-05-19
GitHub Stars
★ 84
Forks
8
License
AGPL-3.0
Primary language
Python

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2025-06-09

KeywordMonthly volume
stratequeue.80

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2025-07-08

Key pages

Weekly snapshots
Home
www.stratequeue.com/ Snapshot 2026-11-08

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does StrateQueue get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is StrateQueue and what platforms does it support?
StrateQueue is catalogued under Investing & Trading: The fastest way from backtest to live trading. Supported platforms: CLI / SDK, API.
Is StrateQueue open source?
StrateQueue has a public repository (https://github.com/StrateQueue/StrateQueue) under the AGPL-3.0 license, recording 84 GitHub stars.Source

Related products in this category

Finance / Investing & Trading

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.